Industry news round-up: updates from April 2024
Discover the latest industry developments in real-world data (RWD) and real-world evidence (RWE) as reported in The Evidence Base from April 2024 in our regular monthly column.
EHR data reveals GLP-1 RA anti-obesity medication trends in Medicare-aged adults
Truveta Research analyzed GLP-1 RA anti-obesity medication usage in US adults aged 60–69, revealing prescription rates under 1%, with disparities between Medicare-aged and younger adults highlighting access challenges despite Medicare guideline changes.
ISPOR 2024: preview of the plenary sessions
The upcoming ISPOR 2024 conference, taking place May 5–8, 2024 in Atlanta, USA, will feature three plenary sessions that will explore the conference theme of HEOR: A Transformative Force for Whole Health. Here’s what to expect from each of the three sessions.
Verantos and CuriMeta collaborate to strengthen real-world evidence generation
Verantos, an artificial intelligence (AI)-powered RWE provider, has partnered with CuriMeta to expand the availability of health data for research.
IVI releases report on integrating equity in HTA
IVI’s new report outlines steps for stakeholders to integrate equity in HTA and address disparities, focusing on data, methods and fair healthcare outcomes.
New report emphasizes need for clear guidance to enhance EU Joint Clinical Assessment for cancer treatments
The EU’s new Health Technology Assessment (HTA) Regulation aims to harmonize clinical assessments of new cancer treatments, but pragmatic guidance is needed to optimize the Joint Clinical Assessment (JCA) process and expedite patient access.
Concerns raised by ARM over EU HTA guidance impacting ATMPs and rare diseases
ARM has expressed concerns about the potential impact the EU HTA Coordination Group’s recent guidance may have on advanced therapy medicinal products (ATMP) and rare diseases.
Flatiron Health and Smirta collaborate to enhance oncology scheduling within OncoEMR platform
Flatiron Health and Smirta collaborate to integrate OncoSmart® into OncoEMR®, enhancing oncology scheduling for improved patient care.
OMNY Health partners with US gastroenterology providers to introduce new real-world data solutions
OMNY Health has announced it is partnering with several US gastroenterology (GI) practices to launch new RWD solutions, aiming to accelerate research and enhance care for millions of people with gastrointestinal diseases across the US.
Industry raises concerns on the feasibility of the joint EU HTA initiative
In a joint industry statement released in April 2024, several leading organizations in the life science sector voiced their concerns about the ‘workability’ of the draft implementing act for the new EU HTA procedure.
Promptly Health and Datavant collaborate to improve health data accessibility
Promptly Health, a European RWD access provider, and Datavant, a health data logistics company, have partnered to improve access to health data in Europe. Integrating Datavant’s technology into Promptly’s Evidence Network aims to streamline Europe’s fragmented health data landscape, benefiting life sciences and hospital partners.
Flatiron and NCCN continue partnership to improve cancer outcomes using real-world insights
The ongoing arrangement between Flatiron Health and the National Comprehensive Cancer Network (NCCN) highlights their joint commitment to using RWD to improve cancer care quality and patient outcomes.
EMA publishes new guidance on real-world evidence generation service
The European Medicines Agency (EMA) has released new guidance detailing the types of studies that can be performed for RWE generation and how they can support RWD studies in the context of regulatory decision-making.
ASH Research Collaborative and Reagan-Udall Foundation for the FDA unite to advance real-world evidence research in sickle cell disease
ASH Research Collaborative (ASH RC) and the Reagan-Udall Foundation for the FDA (FDA Foundation) have launched a consortium to understand and develop consensus on the use of RWE for sickle cell disease research.
COTA and Sanofi collaborate to accelerate multiple myeloma trials through real-world data insights
COTA will partner with Sanofi to expedite cancer trials, focusing on multiple myeloma treatment questions. Their collaboration aims to enhance trial design, improve patient outcomes, and expedite breakthrough treatments using RWD and AI technologies.
HDR UK call for funding to launch a pilot real-world evidence network
Health Data Research UK (HDR UK) is aiming to establish a Coordination Center for a UK RWE network, leveraging the OMOP CDM for cross-national research efficiency.
Verana Health’s Qdata® TED Module leverages real-world data for thyroid eye disease research
Verana Health has launched the Qdata® Thyroid Eye Disease (TED) module, leveraging RWD to aid research and therapy development for TED, aiming to improve patient outcomes.
Truveta releases largest mother–child EHR dataset for maternal and pediatric research
Truveta has released the largest mother–child electronic health record (EHR) dataset with over 1 million pairs, enabling comprehensive maternal and pediatric research while ensuring regulatory compliance.
